Internal Medicine, Rheumatology · Las Vegas, NV
NPI
1184688061
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4475 S Eastern Ave Ste 2400
Las Vegas, NV, 89119
Phone (702) 954-7672
Groups this clinician bills Medicare through
Medicare paid, 2024
$13K
202 services
Medicare patients, 2024
96
Average age 67
Drug cost, 2024
$2.2M
2,824 prescriptions
Company payments, 2025
$157
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Johnson C Kay was code 99214 (office e&m - established), 77 times for 55 patients. In total Johnson C Kay billed 202 services in 14 codes, and Medicare paid $13K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 77 | 55 | $77.47 | $5,965 |
| 99213 Office E&M - Established | Office | 43 | 40 | $58.03 | $2,495 |
| 99204 Office E&M - New | Office | 18 | 18 | $95.66 | $1,722 |
| 99215 Office E&M - Established | Office | 16 | 16 | $130.20 | $2,083 |
By year: 2022 $7,846 for 124 services; 2023 $13K for 174 services; 2024 $13K for 202 services.
Medicare prescription drug claims, 2024
In 2024, the drug Johnson C Kay prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 504 prescriptions and refills. In total Johnson C Kay wrote 2,824 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 504 | 1,318 | 176 | $15K |
| Methotrexate Methotrexate Sodium | 492 | 1,175 | 155 | $6,785 |
| Prednisone Generic | 300 | 691 | 123 | $1,946 |
| Folic Acid Generic | 258 | 763 | 100 | $2,471 |
| Leflunomide Generic | 218 | 525 | 79 | $6,490 |
| Azathioprine Generic | 214 | 409 | 66 | $5,057 |
| Sulfasalazine Generic | 130 | 252 | 43 | $2,041 |
| Mycophenolate Mofetil Generic | 116 | 160 | 30 | $6,201 |
| Humira(Cf) Pen Adalimumab | 66 | 66 | Under 11 | $494K |
| Enbrel Sureclick Etanercept | 61 | 61 | Under 11 | $497K |
| Methylprednisolone Generic | 60 | 60 | 42 | $457 |
| Allopurinol Generic | 39 | 113 | 14 | $341 |
| Pilocarpine Hcl Generic | 35 | 69 | 12 | $2,221 |
| Humira Pen Adalimumab | 29 | 29 | Under 11 | $219K |
| Humira(Cf) Adalimumab | 29 | 29 | Under 11 | $216K |
Brand drugs: - claims; generic drugs: 2,373 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Johnson C Kay $157 ($157 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boston Scientific Corporation with $98.11.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.